UChicago Medicine
J

Bispecifics for LBCL: Guidance for Management of Toxicities in the Community

By UChicago Medicine FEATURING Jennifer Crombie
By UChicago Medicine FEATURING Jennifer Crombie
109 views
July 29, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Related Content

AUTOPLAY
22:11
SOHO Brazil 2024

Has the 1L SoC Truly Changed in Advanced Stage DLBCL?

Feat. A. Zelenetz
30:07
Dipenkumar Modi

Current Management of DLBCL From Frontline to Relapsed Disease

15:26
Moffitt Cancer Center

R/R DLBCL: Are CAR-Ts Superior to Bispecific Antibodies?

Feat. A. Lazaryan
04:29
Juan Pablo Alderuccio

Polatuzumab Vedotin in 1L DLBCL: Perspectives on the POLARIX Trial

40:38
UChicago Medicine

Hematopathology Tumor Board: Case Studies and Diagnostic Challenges …

Feat. G. Venkataraman, A. Perry, K. Cahill, A. Akmatbekov, L. Wu
62:02
UChicago Medicine

New Treatment Strategies in DLBCL

Feat. L. Sehn
16:03
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: The New Algorithm for 2L LBCL

Feat. J. Westin
28:11
Total Health

Hematologic Malignancies Update: Treatment Strategies for AML, DLBCL…

Feat. M. Rotta
33:48
SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: B-Cell Lymphoma

Feat. L. Nastoupil
17:11
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Incorporating Novel Agents in Frontline DLBCL

Feat. L. Sehn
14:17
SOHO Brazil 2024

DLBCL Pts Ineligible for CAR-T Therapy: Do They Exist and How Do We …

Feat. A. Zelenetz
15:29
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Current Standards of Care for Aggressive Lymphomas

Feat. U. Vitolo
16:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Targeted Therapy Updates for Aggressive B-Cell Lymphomas

Feat. D. Landsburg
09:32
SOHO 2023 Eleventh Annual Meeting

Upfront Management of DLBCL

Feat. C. Flowers
35:28
UNC Lineberger Comprehensive Cancer Center

DLBCL Management: Updates for 2023

Feat. N. Grover
13:46
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Smart Stop Trial - Lenalidomide, Tafasitama…

Feat. J. Westin
26:25
Yale Cancer Center

Yale Cancer Center Updates on B-Cell Lymphomas: Exploring MCL, DLBCL…

Feat. S. Kothari
21:58
MedNews Week

The Evolving 1L DLBCL Landscape: POLARIX, Novel Agents and Future Di…

Feat. M. Matasar
15:02
SOHO Brazil 2024

Summary of Updates in R/R DLBCL Treatment

Feat. A. Alencar
18:15
UChicago Medicine

The Next Frontier of Targeted Therapy in Lymphoma

Feat. K. Maddocks